We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

GlaxoSmithKline (GSK) ADRs (Each Representing 2 Ord 0.25p Shares)

Sell:$43.76 Buy:$43.77 Change: $0.42 (0.97%)
Market closed |  Prices as at close on 29 June 2022 | Switch to live prices |
Change: $0.42 (0.97%)
Market closed |  Prices as at close on 29 June 2022 | Switch to live prices |
Change: $0.42 (0.97%)
Market closed |  Prices as at close on 29 June 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

GSK plc, formerly GlaxoSmithKline PLC is a global healthcare company. The Company is focused to improve the quality of human life by helping people. The Company operates through three core businesses: Pharmaceuticals, Vaccines and Consumer Healthcare. Its Pharmaceuticals business has a portfolio of established medicines in respiratory, human immunodeficiency viruses (HIV), immuno-inflammation and oncology. It also focuses on immunology, human genetics, and advanced technologies to deliver transformational new medicines for patients. The Company's research and development focuses on developing vaccines against infectious diseases that combine high medical needs and market potential. The Company's Consumer Healthcare business combines science and consumer insights to create everyday healthcare brands for oral health, pain relief, cold, flu and allergy, digestive health, and vitamins, minerals and supplements. It provides prescription medicines, vaccines, and consumer healthcare products.

Contact details

980 Great West Road
United Kingdom
+44 (20) 80475000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$110.11 billion
Shares in issue:
5.08 billion
New York Stock Exchange
United States
US dollar

Key personnel

  • Emma Walmsley
    Chief Executive Officer, Executive Director
  • Iain Mackay
    Chief Financial Officer, Executive Director
  • Roger Connor
    President - Vaccines and Global Health
  • Brian McNamara
    Chief Executive Officer - GSK Consumer Healthcare
  • Regis Simard
    President - Pharmaceutical Supply Chain
  • Phil Thomson
    President - Global Affairs
  • Deborah Waterhouse
    Chief Executive Officer - ViiV Healthcare
  • Diana Conrad
    Chief People Officer
  • James Ford
    Senior Vice President, Group General Counsel, Legal and Compliance
  • Sally Jackson
    Senior Vice President - Global Communications and CEO Office

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.